ArticleClinical case reports2022

Pasireotide use for the treatment of endogenous hyperinsulinemic hypoglycemia refractory to conventional medical therapy: A case report and review of the literature.

Hasan Husni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.